tetano
Editor, Senior Moderator
Neurologist
. 2022 Nov 15.
doi: 10.1097/NRL.0000000000000472. Online ahead of print.
Optic Perineuritis in an Asymptomatic SARS-CoV-2 Infection
Ryan Kollar[SUP] 1 [/SUP], Smit D Patel[SUP] 1 [/SUP], Neeharika Krothapalli[SUP] 1 [/SUP], Lulu E Yan[SUP] 2 [/SUP], Ian Dimaandal[SUP] 1 [/SUP], Leo J Wolansky[SUP] 3 [/SUP], Mason Leeman-Markowski[SUP] 1 [/SUP], David Waitzman[SUP] 1 [/SUP]
Affiliations
Abstract
Introduction: Optic perineuritis (OPN) is a previously undescribed sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here we present a case of OPN that developed several weeks after initial confirmation of the presence of novel coronavirus RNA in the nasopharynx by polymerase chain reaction assay and subsequent confirmation of SARS-CoV-2 IgG seropositivity in the absence of other systemic inflammatory or infectious markers.
Case report: An asymptomatic 71-year-old man with noninsulin-dependent diabetes mellitus (NIDDM) tested RNA positive for SARS-CoV-2 during a routine screening of patients at a skilled nursing facility. ~3 weeks after the positive SARS-CoV-2 polymerase chain reaction test, the patient developed subacute ophthalmoparesis of the left eye, horizontal diplopia, retro-orbital pain, and frontal headache. An urgent magnetic resonance imaging of the head and orbits suggested OPN. Cerebrospinal fluid studies were without evidence of other infectious, inflammatory, neoplastic, or paraneoplastic processes. He was started on a 5-day course of high-dose intravenous steroids and later transitioned to oral steroid therapy. Sixteen days after the initiation of steroid therapy, the patient had no headache or retro-orbital pain and demonstrated a marked improvement in horizontal gaze.
Conclusion: SARS-CoV-2-associated neurological sequelae have been increasingly recognized during the current coronavirus disease 2019 pandemic. The present case suggests that patients with confirmed SARS-CoV-2 positivity, even without pulmonary or other classic manifestations of active infection, may manifest diverse clinical presentations including postinfectious OPN that could be related to an underlying autoimmune reactive inflammatory response.
. 2022 Nov 15.
doi: 10.1097/NRL.0000000000000472. Online ahead of print.
Optic Perineuritis in an Asymptomatic SARS-CoV-2 Infection
Ryan Kollar[SUP] 1 [/SUP], Smit D Patel[SUP] 1 [/SUP], Neeharika Krothapalli[SUP] 1 [/SUP], Lulu E Yan[SUP] 2 [/SUP], Ian Dimaandal[SUP] 1 [/SUP], Leo J Wolansky[SUP] 3 [/SUP], Mason Leeman-Markowski[SUP] 1 [/SUP], David Waitzman[SUP] 1 [/SUP]
Affiliations
- PMID: 36730679
- DOI: 10.1097/NRL.0000000000000472
Abstract
Introduction: Optic perineuritis (OPN) is a previously undescribed sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here we present a case of OPN that developed several weeks after initial confirmation of the presence of novel coronavirus RNA in the nasopharynx by polymerase chain reaction assay and subsequent confirmation of SARS-CoV-2 IgG seropositivity in the absence of other systemic inflammatory or infectious markers.
Case report: An asymptomatic 71-year-old man with noninsulin-dependent diabetes mellitus (NIDDM) tested RNA positive for SARS-CoV-2 during a routine screening of patients at a skilled nursing facility. ~3 weeks after the positive SARS-CoV-2 polymerase chain reaction test, the patient developed subacute ophthalmoparesis of the left eye, horizontal diplopia, retro-orbital pain, and frontal headache. An urgent magnetic resonance imaging of the head and orbits suggested OPN. Cerebrospinal fluid studies were without evidence of other infectious, inflammatory, neoplastic, or paraneoplastic processes. He was started on a 5-day course of high-dose intravenous steroids and later transitioned to oral steroid therapy. Sixteen days after the initiation of steroid therapy, the patient had no headache or retro-orbital pain and demonstrated a marked improvement in horizontal gaze.
Conclusion: SARS-CoV-2-associated neurological sequelae have been increasingly recognized during the current coronavirus disease 2019 pandemic. The present case suggests that patients with confirmed SARS-CoV-2 positivity, even without pulmonary or other classic manifestations of active infection, may manifest diverse clinical presentations including postinfectious OPN that could be related to an underlying autoimmune reactive inflammatory response.